PGR
55
-3
FITB
56
-2
FE
59
-3
PNW
59
-3
GPC
47
3
EXC
67
-2
URBN
75
12
ABT
59
-6
ADT
73
-6
XOM
40
-2
AME
71
2
RF
63
2
PNC
63
2
CSX
33
2
GT
45
7
KEY
60
2
DTE
49
-5
GD
49
-3
SNA
52
10
L
49
-2
PGR
55
-3
FITB
56
-2
FE
59
-3
PNW
59
-3
GPC
47
3
EXC
67
-2
URBN
75
12
ABT
59
-6
ADT
73
-6
XOM
40
-2
AME
71
2
RF
63
2
PNC
63
2
CSX
33
2
GT
45
7
KEY
60
2
DTE
49
-5
GD
49
-3
SNA
52
10
L
49
-2
Financhill
Back

Apollo Global Management Vs. Keros Therapeutics Industry Stock Comparison

Sell
34

APO
Apollo Global Management

Last Price:
$130.83
Seasonality Move:
5.42%
Sell
29

KROS
Keros Therapeutics

Last Price:
$14.59
Seasonality Move:
-5.28%
Sell
34
Apollo Global Management (APO) is a Sell

Is Apollo Global Management a Buy, Sell or Hold?

  • The current Apollo Global Management [APO] share price is $130.81. The Score for APO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $14.16. The Score for KROS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APO Stock Price Chart

What is Apollo Global Management's stock price today?

  • The Apollo Global Management share price today is $130.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APO is experiencing slight buying pressure.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $14.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing buying pressure, which is a positive indicator for future bullish movement.

APO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.13 Buy
Relative Strength Index (14 RSI): 43.59 Sell
Chaikin Money Flow: 523035 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (128.04 - 141.5) Sell
Bollinger Bands (100): (130.03 - 163.25) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.32 Buy
Relative Strength Index (14 RSI): 59.26 Buy
Chaikin Money Flow: 225838 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.78 - 14.42) Buy
Bollinger Bands (100): (10.55 - 14.07) Buy

APO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 140.07 Sell
20-day SMA: 136.97 Sell
50-day SMA: 133.8 Sell
200-day SMA: 142.65 Sell
8-day EMA: 136.81 Sell
20-day EMA: 136.22 Sell
50-day EMA: 137.21 Sell
200-day EMA: 138.7 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.95 Buy
20-day SMA: 14.08 Buy
50-day SMA: 12.64 Buy
200-day SMA: 32.38 Sell
8-day EMA: 14.03 Buy
20-day EMA: 13.83 Buy
50-day EMA: 13.7 Buy
200-day EMA: 26.58 Sell

Apollo Global Management Earnings Growth & APO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.32 per share, an increase this year of $0.68 per share, and an increase next year of $1.60 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.02 per share, an increase this year of $4.38 per share, and a decrease next year of $4.60 per share.

Apollo Global Management Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):